{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:41:03Z","timestamp":1761442863276,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Health Labour Sciences Research","award":["24131001 to S.T.","25130301 to T.M."],"award-info":[{"award-number":["24131001 to S.T.","25130301 to T.M."]}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development Research","doi-asserted-by":"publisher","award":["17ek0510015h0002 to T.M."],"award-info":[{"award-number":["17ek0510015h0002 to T.M."]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jcyt.2018.05.009","type":"journal-article","created":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T10:55:15Z","timestamp":1534503315000},"page":"1182-1190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Generation of multivirus-specific T cells by a single stimulation of peripheral blood mononuclear cells with a peptide mixture using serum-free medium"],"prefix":"10.1016","volume":"20","author":[{"given":"YURIKO","family":"NISHIYAMA-FUJITA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AI","family":"KAWANA-TACHIKAWA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TOSHIAKI","family":"ONO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUKIE","family":"TANAKA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAKAFUMI","family":"KATO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HELEN E.","family":"HESLOP","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TOMOHIRO","family":"MORIO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SATOSHI","family":"TAKAHASHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2018.05.009_bib0001","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1056\/NEJM199409083311017","article-title":"Donor T cells to treat EBV-associated lymphoma","volume":"331","author":"Heslop","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcyt.2018.05.009_bib0002","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood-2009-08-239186","article-title":"Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients","volume":"115","author":"Heslop","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2018.05.009_bib0003","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1182\/blood-2011-08-371971","article-title":"Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation","volume":"119","author":"Doubrovina","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2018.05.009_bib0004","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(03)14634-X","article-title":"Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines","volume":"362","author":"Peggs","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jcyt.2018.05.009_bib0005","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/CJI.0b013e31815ef862","article-title":"Clinical grade generation of hexon-specific T cells for adoptive T-cell transfer as a treatment of adenovirus infection after allogeneic stem cell transplantation","volume":"31","author":"Feuchtinger","year":"2008","journal-title":"J Immunother"},{"key":"10.1016\/j.jcyt.2018.05.009_bib0006","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/mt.2012.130","article-title":"Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections","volume":"20","author":"Gerdemann","year":"2012","journal-title":"Mol Ther"},{"key":"10.1016\/j.jcyt.2018.05.009_bib0007","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcyt.2016.11.011","article-title":"A consensus introduction to serum replacements and serum-free media for cellular therapies","volume":"19","author":"Karnieli","year":"2017","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2018.05.009_bib0008","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/123030","article-title":"Ex vivo expansion of human mesenchymal stem cells in defined serum-free media","volume":"2012","author":"Jung","year":"2012","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.jcyt.2018.05.009_bib0009","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3109\/14653240903233081","article-title":"Serum-free, xeno-free culture media maintain the proliferation rate and multipotentiality of adipose stem cells in vitro","volume":"11","author":"Lindroos","year":"2009","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2018.05.009_bib0010","doi-asserted-by":"crossref","first-page":"16570","DOI":"10.1038\/srep16570","article-title":"Optimization of human mesenchymal stem cell manufacturing: the effects of animal\/xeno-free media","volume":"5","author":"Oikonomopoulos","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcyt.2018.05.009_bib0011","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1472-6750-10-70","article-title":"Development of a serum-free medium for in vitro expansion of human cytotoxic T lymphocytes using a statistical design","volume":"10","author":"Jeon","year":"2010","journal-title":"BMC Biotechnol"},{"key":"10.1016\/j.jcyt.2018.05.009_bib0012","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1182\/blood-2009-07-232454","article-title":"Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation","volume":"114","author":"Leen","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2018.05.009_bib0013","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1084\/jem.20040613","article-title":"Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers","volume":"202","author":"Cobbold","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jcyt.2018.05.009_bib0014","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2141.2006.06108.x","article-title":"Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation","volume":"134","author":"Feuchtinger","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jcyt.2018.05.009_bib0015","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1182\/blood-2010-01-262089","article-title":"Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation","volume":"116","author":"Feuchtinger","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2018.05.009_bib0016","doi-asserted-by":"crossref","first-page":"242ra83","DOI":"10.1126\/scitranslmed.3008825","article-title":"Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT","volume":"6","author":"Papadopoulou","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jcyt.2018.05.009_bib0017","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1084\/jem.192.8.1105","article-title":"T cells compete for access to antigen-bearing antigen-presenting cells","volume":"192","author":"Kedl","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.jcyt.2018.05.009_bib0018","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ni742","article-title":"T cells down-modulate peptide-MHC complexes on APCs in vivo","volume":"3","author":"Kedl","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jcyt.2018.05.009_bib0019","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1128\/JVI.01689-07","article-title":"Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy","volume":"82","author":"Leen","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.jcyt.2018.05.009_bib0020","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2017.73.0655","article-title":"Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation","volume":"35","author":"Tzannou","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jcyt.2018.05.009_bib0021","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/bmt.2008.403","article-title":"Early reconstitution of effector memory CD4+ CMV-specific T cells protects against CMV reactivation following allogeneic SCT","volume":"43","author":"Pourgheysari","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2018.05.009_bib0022","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM199510193331603","article-title":"Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor","volume":"333","author":"Walter","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcyt.2018.05.009_bib0023","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.4049\/jimmunol.177.3.1427","article-title":"EBV-specific CD4+ T cell clones exhibit vigorous allogeneic responses","volume":"177","author":"Landais","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jcyt.2018.05.009_bib0024","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1182\/blood-2004-05-1918","article-title":"Functional assessment and specific depletion of alloreactive human T cells using flow cytometry","volume":"104","author":"Martins","year":"2004","journal-title":"Blood"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324918305206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324918305206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:35:28Z","timestamp":1761442528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324918305206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1465324918305206"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2018.05.009","relation":{},"ISSN":["1465-3249"],"issn-type":[{"type":"print","value":"1465-3249"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation of multivirus-specific T cells by a single stimulation of peripheral blood mononuclear cells with a peptide mixture using serum-free medium","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2018.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc. on behalf of International Society for Cellular Therapy.","name":"copyright","label":"Copyright"}]}}